New SEC Document(s) for Momenta Pharmaceuticals, Inc.

SEC Filing Alert Momenta Pharmaceuticals, Inc. has filed the following document(s) with the United States Securities and Exchange Commission. Feb 29, 2012 Form 4 / Leicher, Bruce HTML PDF View all SEC Filings

You are subscribed to Momenta Pharmaceuticals, Inc. Investor Relations' e-mail alerts as clotito+biotechdash@gmail.com. To update your e-mail and alert preferences, please click here. To unsubscribe, please click here. Momenta Pharmaceuticals, Inc. 675 West Kendall Street , Cambridge, MA 02142 Service provided by Shareholder.com